OSRH(OSRH)
OSRH
Insider Transactions
Buys (12mo)
0
Sells (12mo)
0
Buy Value (12mo)
--
Net (12mo)
--
| Date | Insider | Title | Type | Price | Shares | Value | Owned After |
|---|---|---|---|---|---|---|---|
| Mar 26, 26 | Kim Yeiseok | COO | Sale | -- | -- | -- | 24.70K |
| Sep 17, 25 | Fierz Reto Kaspar | CTO | Sale | -- | -- | -- | -- |
| Feb 14, 25 | Cho Joong Myung | CTO | Sale | -- | -- | -- | -- |
| Feb 14, 25 | Barberis Alcide | CTO | Sale | -- | -- | -- | -- |
| Feb 14, 25 | Kim Sang Harry | Officer | Sale | -- | -- | -- | -- |
| Feb 14, 25 | Bang Gihyoun | Officer | Sale | -- | -- | -- | -- |
| Feb 14, 25 | Jee Hyuk Joo | CTO | Sale | -- | -- | -- | -- |
| Feb 14, 25 | Bellevue Global Life Science Investors LLC | 10 percent owner | Purchase | -- | 43.00K | -- | 2.04M |
| Feb 14, 25 | Hwang Kuk Hyoun | CEO | Purchase | -- | 3.12M | -- | 12.70M |
| Feb 14, 25 | Hwang Kuk Hyoun | CEO | Purchase | -- | 7.53M | -- | 9.58M |
| Feb 14, 25 | Hwang Kuk Hyoun | CEO | Purchase | -- | 43.00K | -- | 2.04M |
| Feb 14, 25 | Bellevue Capital Management LLC | 10 percent owner | Sale | -- | -- | -- | 3.12M |
| Feb 14, 25 | BCM Europe AG | 10 percent owner | Sale | -- | -- | -- | 7.53M |
| Jun 23, 24 | Kim Sang Hyun | -- | Sale | -- | -- | -- | -- |
| May 27, 24 | Lee Phil Geon | -- | Sale | -- | -- | -- | -- |
| Mar 23, 23 | Hwang Kuk Hyoun | CEO | Sale | -- | 20.00K | -- | 2.00M |
| Mar 23, 23 | Hwang Kuk Hyoun | CEO | Sale | $11.50 | 20.00K | $230.00K | 370.00K |
| Mar 23, 23 | Yoo David Jin | CFO | Purchase | -- | 20.00K | -- | 20.00K |
| Mar 23, 23 | Yoo David Jin | CFO | Purchase | $11.50 | 20.00K | $230.00K | 20.00K |
| Mar 23, 23 | Bellevue Global Life Science Investors LLC | 10 percent owner | Sale | -- | 20.00K | -- | 2.00M |
| Mar 23, 23 | Bellevue Global Life Science Investors LLC | 10 percent owner | Sale | $11.50 | 20.00K | $230.00K | 370.00K |
| Feb 14, 23 | REED STEVEN | CTO | Purchase | -- | 20.00K | -- | 20.00K |
| Feb 14, 23 | REED STEVEN | CTO | Purchase | $11.50 | 20.00K | $230.00K | 20.00K |
| Feb 14, 23 | Chung In Chul | CTO | Purchase | $11.50 | 20.00K | $230.00K | 20.00K |
| Feb 14, 23 | Chung In Chul | CTO | Purchase | -- | 20.00K | -- | 20.00K |
| Feb 14, 23 | Roberts Rad | CTO | Purchase | -- | 20.00K | -- | 20.00K |
| Feb 14, 23 | Park Jin Whan | CTO | Purchase | -- | 20.00K | -- | 20.00K |
| Feb 14, 23 | Euh Hosun | CTO | Purchase | -- | 20.00K | -- | 20.00K |
| Feb 14, 23 | Bellevue Global Life Science Investors LLC | 10 percent owner | Purchase | $10.00 | 430.00K | $4.30M | 1.80M |
| Feb 14, 23 | Bellevue Global Life Science Investors LLC | 10 percent owner | Sale | -- | 20.00K | -- | 1.71M |
| Feb 14, 23 | Bellevue Global Life Science Investors LLC | 10 percent owner | Sale | -- | 20.00K | -- | 1.69M |
| Feb 14, 23 | Bellevue Global Life Science Investors LLC | 10 percent owner | Sale | -- | 20.00K | -- | 1.67M |
| Feb 14, 23 | Bellevue Global Life Science Investors LLC | 10 percent owner | Sale | -- | 20.00K | -- | 1.65M |
| Feb 14, 23 | Bellevue Global Life Science Investors LLC | 10 percent owner | Sale | -- | 20.00K | -- | 1.63M |
| Feb 14, 23 | Bellevue Global Life Science Investors LLC | 10 percent owner | Sale | -- | 225.00K | -- | 1.40M |
| Feb 14, 23 | Bellevue Global Life Science Investors LLC | 10 percent owner | Sale | -- | 30.00K | -- | 1.37M |
| Feb 14, 23 | Bellevue Global Life Science Investors LLC | 10 percent owner | Purchase | $11.50 | 430.00K | $4.95M | 430.00K |
| Feb 14, 23 | Bellevue Global Life Science Investors LLC | 10 percent owner | Sale | $11.50 | 20.00K | $230.00K | 410.00K |
| Feb 14, 23 | Bellevue Global Life Science Investors LLC | 10 percent owner | Sale | $11.50 | 20.00K | $230.00K | 390.00K |
| Feb 14, 23 | Hwang Kuk Hyoun | CEO | Purchase | $10.00 | 430.00K | $4.30M | 1.80M |
| Feb 14, 23 | Hwang Kuk Hyoun | CEO | Sale | -- | 20.00K | -- | 1.71M |
| Feb 14, 23 | Hwang Kuk Hyoun | CEO | Sale | -- | 20.00K | -- | 1.69M |
| Feb 14, 23 | Hwang Kuk Hyoun | CEO | Sale | -- | 20.00K | -- | 1.67M |
| Feb 14, 23 | Hwang Kuk Hyoun | CEO | Sale | -- | 20.00K | -- | 1.65M |
| Feb 14, 23 | Hwang Kuk Hyoun | CEO | Sale | -- | 20.00K | -- | 1.63M |
| Feb 14, 23 | Hwang Kuk Hyoun | CEO | Sale | -- | 225.00K | -- | 1.40M |
| Feb 14, 23 | Hwang Kuk Hyoun | CEO | Sale | -- | 30.00K | -- | 1.37M |
| Feb 14, 23 | Hwang Kuk Hyoun | CEO | Purchase | $11.50 | 430.00K | $4.95M | 430.00K |
| Feb 14, 23 | Hwang Kuk Hyoun | CEO | Sale | $11.50 | 20.00K | $230.00K | 410.00K |
| Feb 14, 23 | Hwang Kuk Hyoun | CEO | Sale | $11.50 | 20.00K | $230.00K | 390.00K |
| Feb 9, 23 | Chung In Chul | -- | Sale | -- | -- | -- | -- |
| Feb 9, 23 | Roberts Rad | -- | Sale | -- | -- | -- | -- |
| Feb 9, 23 | Yoo David Jin | CFO | Sale | -- | -- | -- | -- |
| Feb 9, 23 | Euh Hosun | -- | Sale | -- | -- | -- | -- |
| Feb 9, 23 | Bellevue Global Life Science Investors LLC | 10 percent owner | Sale | -- | -- | -- | 1.73M |
| Feb 9, 23 | REED STEVEN | -- | Sale | -- | -- | -- | -- |
| Feb 9, 23 | Park Jin Whan | -- | Sale | -- | -- | -- | -- |
| Feb 9, 23 | Whang Jun Chul | CTO | Sale | -- | -- | -- | -- |
| Feb 9, 23 | Hwang Kuk Hyoun | CTO | Sale | -- | -- | -- | 1.73M |